help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VASSILAKIS, D. A.
Right arrow Articles by BOUROS, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VASSILAKIS, D. A.
Right arrow Articles by BOUROS, D.

Am. J. Respir. Crit. Care Med., Volume 160, Number 5, November 1999, 1729-1733

Microsatellite DNA Instability and Loss of Heterozygosity in Pulmonary Sarcoidosis

DIMITRIS A. VASSILAKIS, GEORGE SOURVINOS, MILTIADIS MARKATOS, KOSTAS PSATHAKIS, DEMETRIOS A. SPANDIDOS, NIKOLAOS M. SIAFAKAS, and DEMOSTHENES BOUROS

Department of Pneumonology and Laboratory of Virology, Medical School, University of Crete, Heraklion, Greece; and University Hospital, Heraklion, Greece

In the present study we investigated the incidence of microsatellite instability (MI) and loss of heterozygosity (LOH) in sarcoidosis, a multisystem disease of unknown origin. We examined sputum cytological specimens from 30 patients with sarcoidosis and 30 healthy, matched subjects, using 10 highly polymorphic microsatellite markers located at several chromosomal arms. The electrophoretic pattern of each specimen was compared with the corresponding pattern of peripheral blood and any difference in the mobility of the microsatellite alleles was interpreted as MI-positive. LOH was scored as decrease in intensity of one allele relative to the other as determined from comparison of sputum and normal (blood) DNA. We found that 14 (47%) sarcoidosis patients showed genetic alterations, either MI or LOH. Six (20%) patients exhibited MI and nine (30%) exhibited LOH in at least one microsatellite marker. One of the patients exhibited MI in two microsatellite markers and three (10%) showed LOH in more than one marker. One patient showed complete deletion of the chromosomal arm 17q11.2-q21. None of the healthy subjects exhibited any genetic alteration in the studied markers. No correlation was found between the genetic alterations detected and age, disease duration, blood gases, or spirometric parameters of the patients. Our findings suggest that MI is a detectable phenomenon in sarcoidosis and seems not to be related with the severity of the disease. The detection of LOH indicates the presence of putative tumor suppressor genes at loci examined, which may play an important role in the etiopathogenesis of sarcoidosis. Vassilakis DA, Sourvinos G, Markatos M, Psathakis K, Spandidos DA, Siafakas NM, Bouros D. Microsatellite instability and loss of heterozygosity in pulmonary sarcoidosis.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. M. Majka, M. Skokan, L. Wheeler, J. Harral, S. Gladson, E. Burnham, J. E. Loyd, K. R. Stenmark, M. Varella-Garcia, and J. West
Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L1028 - L1039.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Makris, N. Tzanakis, A. Damianaki, E. Ntaoukakis, E. Neofytou, M. Zervou, N. M. Siafakas, and E. G. Tzortzaki
Microsatellite DNA instability and COPD exacerbations
Eur. Respir. J., September 1, 2008; 32(3): 612 - 618.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. Paraskakis, G. Sourvinos, F. Passam, N. Tzanakis, E.G. Tzortzaki, M. Zervou, D. Spandidos, and N.M. Siafakas
Microsatellite DNA instability and loss of heterozygosity in bronchial asthma
Eur. Respir. J., December 1, 2003; 22(6): 951 - 955.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.K. Field and J.H. Youngson
The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Eur. Respir. J., August 1, 2002; 20(2): 464 - 479.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Bouros, K. Hatzakis, H. Labrakis, and K. Zeibecoglou
Association of Malignancy With Diseases Causing Interstitial Pulmonary Changes*
Chest, April 1, 2002; 121(4): 1278 - 1289.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G.M. Verleden, R.M. du Bois, D. Bouros, M. Drent, A. Millar, J. Muller-Quernheim, G. Semenzato, S. Johnson, G. Sourvinos, D. Olivieri, et al.
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin
Eur. Respir. J., July 1, 2001; 18(32_suppl): 17S - 29s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. A. VASSILAKIS, G. SOURVINOS, D. A. SPANDIDOS, N. M. SIAFAKAS, and D. BOUROS
Frequent Genetic Alterations at the Microsatellite Level in Cytologic Sputum Samples of Patients with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1115 - 1119.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society 		  ATS Par News